Evidence map›Paper›PMID 25355872›Full record

ArticleJournal of virology2015

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

Subing Cao, Michael J Strong, Xia Wang, Walter N Moss, Monica Concha, Zhen Lin, Tina O'Grady, Melody Baddoo, Claire Fewell, Rolf Renne and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Kmerator Suite: design of specificNAR genomics and bioinformatics · 2021
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Subing CaoTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Michael J StrongTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.ORCID http://orcid.org/0000-0001-9930-3578
Xia WangTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Walter N MossDepartment of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Monica ConchaTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Zhen LinTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Tina O'GradyTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Melody BaddooTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Claire FewellTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA.
Rolf RenneDepartment of Molecular Genetics Microbiology, University of Florida, Gainesville, Florida, USA.
Erik K FlemingtonTulane Health Sciences Center and Tulane Cancer Center, New Orleans, Louisiana, USA eflemin@tulane.edu.
Howard Hughes Medical Institute · USUniversity of Florida · US

Funding

Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
Studying the role of KSHV-encoded miRNAsR01CA119917 · NCI · UNIVERSITY OF FLORIDA · PI RENNE, ROLF F · 2008 to 2017
$3.2M
Epstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9M
Intercellular communication in Epstein Barr virus reactivationR01AI101046 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2012 to 2016
$1.9M
Role of the cellular microRNA, miR-155, in EBV type III latency signalingR01CA138268 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2009 to 2013
$1.5M
Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesisF30CA177267 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI STRONG, MICHAEL JAMES · 2013 to 2016
$129k
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell LymphomaF31CA180449 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI O'GRADY, CHRISTINA M · 2013 to 2015
$116k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA177267NCI NIH HHS F30CA177267NCI NIH HHS F31 CA180449NCI NIH HHS F31CA180449NCI NIH HHS R01 CA119917NCI NIH HHS R01CA119917NCI NIH HHS R01 CA138268NCI NIH HHS R01CA138268NIAID NIH HHS R01 AI101046NIAID NIH HHS R01AI101046NIAID NIH HHS R01 AI106676NIAID NIH HHS R01AI106676NIGMS NIH HHS P20 GM103518NIGMS NIH HHS P20GM103518
6 · The paper itself

Abstract

unlabelledUsing high-throughput RNA sequencing data from 50 common lymphoma cell culture models from the Cancer Cell Line Encyclopedia project, we performed an unbiased global interrogation for the presence of a panel of 740 viruses and strains known to infect human and other mammalian cells. This led to the findings of previously identified infections by Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (KSHV), and human T-lymphotropic virus type 1 (HTLV-1). In addition, we also found a previously unreported infection of one cell line (DEL) with a murine leukemia virus. High expression of murine leukemia virus (MuLV) transcripts was observed in DEL cells, and we identified four transcriptionally active integration sites, one being in the TNFRSF6B gene. We also found low levels of MuLV reads in a number of other cell lines and provided evidence suggesting cross-contamination during sequencing. Analysis of HTLV-1 integrations in two cell lines, HuT 102 and MJ, identified 14 and 66 transcriptionally active integration sites with potentially activating integrations in immune regulatory genes, including interleukin-15 (IL-15), IL-6ST, STAT5B, HIVEP1, and IL-9R. Although KSHV and EBV do not typically integrate into the genome, we investigated a previously identified integration of EBV into the BACH2 locus in Raji cells. This analysis identified a BACH2 disruption mechanism involving splice donor sequestration. Through viral gene expression analysis, we detected expression of stable intronic RNAs from the EBV BamHI W repeats that may be part of long transcripts spanning the repeat region. We also observed transcripts at the EBV vIL-10 locus exclusively in the Hodgkin's lymphoma cell line, Hs 611.T, the expression of which were uncoupled from other lytic genes. Assessment of the KSHV viral transcriptome in BCP-1 cells showed expression of the viral immune regulators, K2/vIL-6, K4/vIL-8-like vCCL1, and K5/E2-ubiquitin ligase 1 that was significantly higher than expression of the latency-associated nuclear antigen. Together, this investigation sheds light into the virus composition across these lymphoma model systems and provides insights into common viral mechanistic principles. IMPORTANCE: Viruses cause cancer in humans. In lymphomas the Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (KSHV) and human T-lymphotropic virus type 1 are major contributors to oncogenesis. We assessed virus-host interactions using a high throughput sequencing method that facilitates the discovery of new virus-host associations and the investigation into how the viruses alter their host environment. We found a previously unknown murine leukemia virus infection in one cell line. We identified cellular genes, including cytokine regulators, that are disrupted by virus integration, and we determined mechanisms through which virus integration causes deregulation of cellular gene expression. Investigation into the KSHV transcriptome in the BCP-1 cell line revealed high-level expression of immune signaling genes. EBV transcriptome analysis showed expression of vIL-10 transcripts in a Hodgkin's lymphoma that was uncoupled from lytic genes. These findings illustrate unique mechanisms of viral gene regulation and to the importance of virus-mediated host immune signaling in lymphomas.

Indexed as

High-Throughput Nucleotide SequencingCell Line, TumorGene Expression ProfilingHerpesviridaeHumansLymphomaRetroviridaeVirus Integration

Identifiers

PMID25355872
PMCPMC4301145
OpenAlexW2044365017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.